熱門資訊> 正文

ZimVie在美国推出GenTek恢复组件

2024-07-24 00:37

ZimVie (NASDAQ:ZIMV) said it has launched its GenTek Genuine Restorative Components portfolio in the U.S. after receiving market clearance from the FDA.
The GenTek product portfolio has been on the market in Europe since 2019. The products are designed to work with ZimVie’s dental implant systems.

More on ZimVie

ZimVie: Guidance Suggests Company Fairly Valued At The Moment (Rating Downgrade)
ZimVie Inc. (ZIMV) Q1 2024 Earnings Call Transcript
ZimVie jumps after report on buyout talks with South Korea’s Osstem
ZimVie may be worth $25-$29 a share in takeover - analyst
Seeking Alpha’s Quant Rating on ZimVie

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。